APTO
Price
$1.20
Change
+$0.01 (+0.84%)
Updated
May 3, 6:59 PM EST
SLNO
Price
$45.12
Change
-$4.11 (-8.35%)
Updated
May 3, 6:59 PM EST
11 days until earnings call
Ad is loading...

APTO vs SLNO ᐉ Comparison: Which is Better to Invest?

Header iconAPTO vs SLNO Comparison
Open Charts APTO vs SLNOBanner chart's image
Aptose Biosciences
Price$1.20
Change+$0.01 (+0.84%)
Volume$20.6K
CapitalizationN/A
Soleno Therapeutics
Price$45.12
Change-$4.11 (-8.35%)
Volume$912.24K
CapitalizationN/A
View a ticker or compare two or three
APTO vs SLNO Comparison Chart

Loading...

APTODaily Signal changed days agoGain/Loss if shorted
 
Show more...
SLNODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
APTO vs. SLNO commentary
May 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTO is a Hold and SLNO is a Hold.

COMPARISON
Comparison
May 04, 2024
Stock price -- (APTO: $1.19 vs. SLNO: $49.23)
Brand notoriety: APTO and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTO: 44% vs. SLNO: 75%
Market capitalization -- APTO: $19.54M vs. SLNO: $1.64B
APTO [@Biotechnology] is valued at $19.54M. SLNO’s [@Biotechnology] market capitalization is $1.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTO’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • APTO’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both APTO and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTO’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 5 bullish TA indicator(s).

  • APTO’s TA Score: 4 bullish, 4 bearish.
  • SLNO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than APTO.

Price Growth

APTO (@Biotechnology) experienced а +2.59% price change this week, while SLNO (@Biotechnology) price change was +31.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.27%. For the same industry, the average monthly price growth was -0.50%, and the average quarterly price growth was +1243.13%.

Reported Earning Dates

APTO is expected to report earnings on Aug 10, 2023.

SLNO is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for APTO with price predictions.
OPEN
A.I.dvisor published
a Summary for SLNO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SLNO($1.64B) has a higher market cap than APTO($19.5M). SLNO YTD gains are higher at: 22.311 vs. APTO (-53.150).
APTOSLNOAPTO / SLNO
Capitalization19.5M1.64B1%
EBITDAN/AN/A-
Gain YTD-53.15022.311-238%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
APTO vs SLNO: Fundamental Ratings
APTO
SLNO
OUTLOOK RATING
1..100
326
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9534
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APTO's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for SLNO (99) in the Medical Specialties industry. This means that APTO’s stock grew somewhat faster than SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as APTO (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to APTO’s over the last 12 months.

SLNO's SMR Rating (97) in the Medical Specialties industry is in the same range as APTO (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to APTO’s over the last 12 months.

SLNO's Price Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for APTO (95) in the Biotechnology industry. This means that SLNO’s stock grew somewhat faster than APTO’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as APTO (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to APTO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOSLNO
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APTODaily Signal changed days agoGain/Loss if shorted
 
Show more...
SLNODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VEXPX113.131.20
+1.07%
Vanguard Explorer Inv
VIPAX26.800.28
+1.06%
Voya Index Plus LargeCap Port ADV
AGLOX16.010.16
+1.01%
Ariel Global Investor
PAEEX19.720.19
+0.97%
Putnam Dynamic Asset Allocation Gr R6
FSBLX19.150.18
+0.95%
Federated Hermes Global Allocation R6

APTO and

Correlation & Price change

A.I.dvisor tells us that APTO and BDTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTO and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTO
1D Price
Change %
APTO100%
-1.65%
BDTX - APTO
30%
Poorly correlated
+11.69%
MDGL - APTO
28%
Poorly correlated
+2.59%
SLNO - APTO
28%
Poorly correlated
+3.55%
ORMP - APTO
26%
Poorly correlated
N/A
TRVN - APTO
26%
Poorly correlated
+6.70%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been closely correlated with IMVT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if SLNO jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+3.55%
IMVT - SLNO
79%
Closely correlated
+0.91%
BRNS - SLNO
56%
Loosely correlated
-2.50%
KA - SLNO
45%
Loosely correlated
+1.81%
ROIV - SLNO
40%
Loosely correlated
+0.27%
FRTX - SLNO
37%
Loosely correlated
-2.67%
More